Beta

Lifemd, inc.LFMDP.US Overview

US StockHealthcare
(No presentation for LFMDP)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

LFMDP AI Insights

LFMDP Overall Performance

LFMDP AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

LFMDP Recent Performance

-0.40%

Lifemd, inc.

-1.10%

Avg of Sector

-0.49%

S&P500

LFMDP PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check LFMDP's Trend

LFMDP Key Information

LFMDP Valuation Metrics

LFMDP Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Price of LFMDP

LFMDP FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

LFMDP Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.88
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
11.02
METRIC
VALUE
vs. INDUSTRY
Gross Margin
86.38%
Net Margin
-2.55%
Revenue Growth (YoY)
10.65%
Profit Growth (YoY)
7.80%
3-Year Revenue Growth
18.57%
3-Year Profit Growth
16.83%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.88
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
11.02
Gross Margin
86.38%
Net Margin
-2.55%
Revenue Growth (YoY)
10.65%
Profit Growth (YoY)
7.80%
3-Year Revenue Growth
18.57%
3-Year Profit Growth
16.83%

  • When is LFMDP's latest earnings report released?

    The most recent financial report for Lifemd, inc. (LFMDP) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating LFMDP's short-term business performance and financial health. For the latest updates on LFMDP's earnings releases, visit this page regularly.

  • What is the operating profit of LFMDP?

    According to the latest financial report, Lifemd, inc. (LFMDP) reported an Operating Profit of -1.1M with an Operating Margin of -2.34% this period, representing a decline of 207.81% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is LFMDP's revenue growth?

    In the latest financial report, Lifemd, inc. (LFMDP) announced revenue of 46.87M, with a Year-Over-Year growth rate of -27.06%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does LFMDP have?

    At the end of the period, Lifemd, inc. (LFMDP) held Total Cash and Cash Equivalents of 36.79M, accounting for 0.52 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does LFMDP go with three margins increasing?

    In the latest report, Lifemd, inc. (LFMDP) did not achieve the “three margins increasing” benchmark, with a gross margin of -165%%, operating margin of -122.96%%, and net margin of 315.92%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess LFMDP's profit trajectory and future growth potential.

  • Is LFMDP's EPS continuing to grow?

    According to the past four quarterly reports, Lifemd, inc. (LFMDP)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of LFMDP?

    Lifemd, inc. (LFMDP)'s Free Cash Flow (FCF) for the period is -3.44M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 198.16% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of LFMDP?

    The latest valuation data shows Lifemd, inc. (LFMDP) has a Price-To-Earnings (PE) ratio of 2.12 and a Price/Earnings-To-Growth (PEG) ratio of -0.04. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.